The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Newcastle Disease Vaccine Market Research Report 2024

Global Newcastle Disease Vaccine Market Research Report 2024

Publishing Date : Jan, 2024

License Type :

Report Code : 1410638

No of Pages : 90

Ask Your Query

Report Description
Table of Content

Synopsis
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
The global Newcastle Disease Vaccine market was valued at US$ 314.8 million in 2023 and is anticipated to reach US$ 396.2 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
This report aims to provide a comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease Vaccine.
Report Scope
The Newcastle Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newcastle Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newcastle Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Chicken
Duck & Goose
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Newcastle Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Newcastle Disease Vaccine Market Overview
1.1 Product Overview and Scope of Newcastle Disease Vaccine
1.2 Newcastle Disease Vaccine Segment by Type
1.2.1 Global Newcastle Disease Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine Segment by Application
1.3.1 Global Newcastle Disease Vaccine Market Value by Application: (2024-2030)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Newcastle Disease Vaccine Revenue 2019-2030
1.4.2 Global Newcastle Disease Vaccine Sales 2019-2030
1.4.3 Global Newcastle Disease Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Newcastle Disease Vaccine Market Competition by Manufacturers
2.1 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Newcastle Disease Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Newcastle Disease Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Newcastle Disease Vaccine, Product Type & Application
2.7 Newcastle Disease Vaccine Market Competitive Situation and Trends
2.7.1 Newcastle Disease Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Newcastle Disease Vaccine Players Market Share by Revenue
2.7.3 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Newcastle Disease Vaccine Retrospective Market Scenario by Region
3.1 Global Newcastle Disease Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Newcastle Disease Vaccine Global Newcastle Disease Vaccine Sales by Region: 2019-2030
3.2.1 Global Newcastle Disease Vaccine Sales by Region: 2019-2024
3.2.2 Global Newcastle Disease Vaccine Sales by Region: 2025-2030
3.3 Global Newcastle Disease Vaccine Global Newcastle Disease Vaccine Revenue by Region: 2019-2030
3.3.1 Global Newcastle Disease Vaccine Revenue by Region: 2019-2024
3.3.2 Global Newcastle Disease Vaccine Revenue by Region: 2025-2030
3.4 North America Newcastle Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Newcastle Disease Vaccine Sales by Country (2019-2030)
3.4.3 North America Newcastle Disease Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Newcastle Disease Vaccine Sales by Country (2019-2030)
3.5.3 Europe Newcastle Disease Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Newcastle Disease Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Newcastle Disease Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Newcastle Disease Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Newcastle Disease Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Newcastle Disease Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Newcastle Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Newcastle Disease Vaccine Sales by Type (2019-2030)
4.1.1 Global Newcastle Disease Vaccine Sales by Type (2019-2024)
4.1.2 Global Newcastle Disease Vaccine Sales by Type (2025-2030)
4.1.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Newcastle Disease Vaccine Revenue by Type (2019-2030)
4.2.1 Global Newcastle Disease Vaccine Revenue by Type (2019-2024)
4.2.2 Global Newcastle Disease Vaccine Revenue by Type (2025-2030)
4.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Newcastle Disease Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Newcastle Disease Vaccine Sales by Application (2019-2030)
5.1.1 Global Newcastle Disease Vaccine Sales by Application (2019-2024)
5.1.2 Global Newcastle Disease Vaccine Sales by Application (2025-2030)
5.1.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Newcastle Disease Vaccine Revenue by Application (2019-2030)
5.2.1 Global Newcastle Disease Vaccine Revenue by Application (2019-2024)
5.2.2 Global Newcastle Disease Vaccine Revenue by Application (2025-2030)
5.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Newcastle Disease Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merial Newcastle Disease Vaccine Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 CEVA
6.2.1 CEVA Corporation Information
6.2.2 CEVA Description and Business Overview
6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
6.2.5 CEVA Recent Developments/Updates
6.3 QYH Biotech
6.3.1 QYH Biotech Corporation Information
6.3.2 QYH Biotech Description and Business Overview
6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
6.3.5 QYH Biotech Recent Developments/Updates
6.4 Ringpu Biology
6.4.1 Ringpu Biology Corporation Information
6.4.2 Ringpu Biology Description and Business Overview
6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
6.4.5 Ringpu Biology Recent Developments/Updates
6.5 Yebio
6.5.1 Yebio Corporation Information
6.5.2 Yebio Description and Business Overview
6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
6.5.5 Yebio Recent Developments/Updates
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Corporation Information
6.6.2 Harbin Veterinary Research Institute Description and Business Overview
6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
6.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 DHN
6.8.1 DHN Corporation Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 DHN Newcastle Disease Vaccine Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 Zoetis
6.9.1 Zoetis Corporation Information
6.9.2 Zoetis Description and Business Overview
6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
6.9.5 Zoetis Recent Developments/Updates
6.10 ChengDu Tecbond
6.10.1 ChengDu Tecbond Corporation Information
6.10.2 ChengDu Tecbond Description and Business Overview
6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
6.10.5 ChengDu Tecbond Recent Developments/Updates
6.11 Elanco (Lohmann)
6.11.1 Elanco (Lohmann) Corporation Information
6.11.2 Elanco (Lohmann) Newcastle Disease Vaccine Description and Business Overview
6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
6.11.5 Elanco (Lohmann) Recent Developments/Updates
6.12 FATRO
6.12.1 FATRO Corporation Information
6.12.2 FATRO Newcastle Disease Vaccine Description and Business Overview
6.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
6.12.5 FATRO Recent Developments/Updates
6.13 CAVAC
6.13.1 CAVAC Corporation Information
6.13.2 CAVAC Newcastle Disease Vaccine Description and Business Overview
6.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
6.13.5 CAVAC Recent Developments/Updates
6.14 Vaksindo
6.14.1 Vaksindo Corporation Information
6.14.2 Vaksindo Newcastle Disease Vaccine Description and Business Overview
6.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
6.14.5 Vaksindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Newcastle Disease Vaccine Industry Chain Analysis
7.2 Newcastle Disease Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Newcastle Disease Vaccine Production Mode & Process
7.4 Newcastle Disease Vaccine Sales and Marketing
7.4.1 Newcastle Disease Vaccine Sales Channels
7.4.2 Newcastle Disease Vaccine Distributors
7.5 Newcastle Disease Vaccine Customers
8 Newcastle Disease Vaccine Market Dynamics
8.1 Newcastle Disease Vaccine Industry Trends
8.2 Newcastle Disease Vaccine Market Drivers
8.3 Newcastle Disease Vaccine Market Challenges
8.4 Newcastle Disease Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Advanced Wound Care-Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Medical Ultrasound-Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Stone Baskets-Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Ureteral Access Sheath-Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Ultrasonic Tissue Ablation System-Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}